Switching from a Non-Protease Inhibitor-Based Regimen to the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice [Corrigendum]
-
Published:2022-10
Issue:
Volume:Volume 16
Page:3737-3738
-
ISSN:1177-8881
-
Container-title:Drug Design, Development and Therapy
-
language:en
-
Short-container-title:DDDT
Author:
Ranzenigo Martina,
Gianotti NicolaORCID,
Galli Laura,
Poli Andrea,
Mastrangelo Andrea,
Bruzzesi Elena,
Chiurlo Matteo,
Nozza Silvia,
Bossolasco Simona,
Spagnuolo VincenzoORCID,
Mancusi DanielaORCID,
Termini RobertaORCID,
Carini Elisabetta,
Lazzarin Adriano,
Castagna Antonella
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology